Loading viewer...
earnings
Format: PDF earnings
Telix Pharmaceuticals' H1 2024 interim results presentation delivered on 22 August 2024. The presentation covers financial and operational achievements for the first half of 2024, including updates on the company's lead product Illuccix® for prostate cancer imaging, which has received regulatory approvals in Australia, the United States, and Canada.
annual_report
14 Pages
earnings
30 Pages
Alma Media
SS&C Technologies Q1 2024 Earnings Results
earningsearnings
20 Pages
SS&C Technologies
L3Harris 2023 Q4 Earnings Presentation January 2024
earningsearnings
14 Pages
L3Harris Technologies
Live Oak Bancshares Q4 2016 Earnings Presentation
earningsearnings
13 Pages
Live Oak Bancshares
Hong Leong Financial Group 1H FY24 Earnings Results Presentation
earningsearnings
24 Pages
Hong Leong Financial Group Berhad